Clik here to view.
Legal costs push C.R. Bard to Q2 red
C.R. Bard shares dipped today after the company reported a swing to 2nd-quarter losses and more than $290 million in charges associated with patient injury lawsuits.C.R. Bard (NYSE:BCR) shares dipped a...
View ArticleClik here to view.
Diabetes: FDA warns 15 cos. on false labeling
Federal healthcare regulators warn a slew of foreign and domestic companies who claim to sell products that mitigate, treat, cure or prevent diabetes.The FDA this week warned consumers about a slew of...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for July 23, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Can hackers and medical device makers play nice?
Good-guy hackers and medical device makers may not seem like natural allies, but the communities are colliding more and more as security experts uncover and report potential vulnerabilities in...
View ArticleClik here to view.
Brigham & Women's surgeon arrested for assaulting a cop | MassDevice.com On Call
A prominent heart surgeon at Brigham & Women's Hospital allegedly ran over a trooper's foot at Logan Airport and was arrested in the Ted Williams Tunnel for assault and battery.MASSDEVICE ON CALL —...
View ArticleClik here to view.
Building a whole heart for children born with half: Q&A with a cardiac surgeon
Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching...
View ArticleClik here to view.
DARPA grants $23M contract to Battelle, NxStage and Aethlon for a sepsis...
Battelle, NxStage and Aethlon will collaborate on a mobile medical device to treat sepsis in soldiers, funded by a $23M contract with DARPA.News Well, Blood Management, Deals Roundup, Dialysisread more
View ArticleClik here to view.
Recall: FDA slaps Ohio-based Bryan Medical with its highest-risk recall
Ohio-based airway management company Bryan Medical gets the FDA's highest-risk Class I recall for a mislabeling issue among its pediatric trachea tubes.The FDA slapped its highest-risk label on a...
View ArticleClik here to view.
Boston Scientific hits 52-week high on swing to Q2 black
Shares of Boston Scientific hit a 52-week high today after the medical device company posted black ink for the 2nd quarter and boosted the lower end of its sales outlook for the rest of the year.Boston...
View ArticleClik here to view.
Alimera's Iluvien vision repair implant wins national insurance coverage in...
France grants Alimera's Iluvien vision repair implant national insurance coverage, with up to 100% reimbursement for certain patients.The French National Health Authority granted Alimera Sciences...
View ArticleClik here to view.
Boston Scientific’s next-gen imaging catheter lands regulatory wins in 3...
Boston Scientific touts a European CE Mark, U.S. FDA clearance and Japanese PMDA for its OptiCross coronary imaging catheter.Boston Scientific (NYSE:BSX) landed regulatory wins in 3 major global...
View ArticleClik here to view.
Zimmer's Q2 profits slide nearly 30%
Second-quarter profits for medical device company Zimmer Holdings fall nearly 30% as it logs a nearly $50 million charge for legal claims against its recalled Durom hip implant.Zimmer (NYSE:ZMH) shares...
View ArticleClik here to view.
Repeal the medical device tax, encourage medical technology innovation
B. Braun Medical chairman & CEO Caroll Neubauer on why the medical device tax needs to be repealed. By Caroll Neubauer News Well, Medical Device Taxread more
View ArticleClik here to view.
Johnson & Johnson subsidiary gets Class I recall for implantable infusion pumps
Codman & Shurtleff, a division of Johnson & Johnson subsidiary DePuy Synthes, gets the FDA's highest warning level for issues with certain lots of its programmable infusion pumps.News Well,...
View ArticleClik here to view.
Second Sight eyes $10M funding round | Wall Street Beat
Second Sight Medical registers for a $10 million funding round to back its Argus II 'bionic eye' retinal implant.Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing,...
View ArticleClik here to view.
Varian struggles in Japan in Q3, adjusts full-year guidance
Varian battles significant Japanese headwinds during its 3rd quarter, with declines in its X-ray tube business off-setting progress in other divisions.Varian Medical Systems (NYSE:VAR) got a little...
View ArticleClik here to view.
NxStage Medical pares losses and boosts sales, but still takes a hit on Wall...
NxStage Medical shares dive nearly 4% on Wall Street today, despite higher revenues and narrowed losses in the 2nd quarter.NxStage Medical (NSDQ:NXTM) beat the Street's earnings-per-share estimate by 1...
View ArticleClik here to view.
Invacare makes progress during 'most challenging year'
Invacare gains a few points on Wall Street despite sinking sales and widening losses as the company sees the light at the end of an FDA consent decree effectively shutting down 2 company...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for July 24, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Q2 profits surge for Edwards Lifesciences
Edwards Lifesciences reports a nearly 40% surge in 2nd-quarter profits on upper-single-digit sales growth.Edwards Lifesciences (NYSE:EW) posted surging 2nd-quarter profits on modest sales growth,...
View Article
